H1 Blog

DECEMBER 4, 2023

As the pharmaceutical and biotech industries continue to push for faster drug development, the importance of equity and diversity in clinical trial recruitment cannot be overlooked. Let’s dive in to uncover the role of digital health and data in driving faster drug development through improved diversity.

Clinical Trials 59

Clinical Trials Trials Pharmaceutical Companies Pharmaceuticals 59

Drug Target Review

JULY 18, 2023

Artificial Intelligence (AI) is poised to transform the field of target discovery in drug development, offering immense potential to enhance efficacy, personalised medicine, and accelerate the development of innovative compounds. With support from pharmaceutical companies, ultimately, the answer to this question should be yes.

Drug Development 98

Drug Development Drugs Pharmaceutical Companies Clinical Development 98

Drug Discovery World

SEPTEMBER 26, 2022

It’s common knowledge that drug discovery and development is costly, lengthy and has no guarantee of success. It’s why pharmaceutical companies will often spend up to 10 years and upwards of $1 billion before receiving regulatory approval for a drug.

Pharmaceutical Companies 130

Pharmaceutical Companies Drugs Pharmaceuticals Clinical Trials 130

Drug Discovery World

JUNE 2, 2023

With National Cancer Research Month coming to an end and the American Society of Clinical Oncology Annual Meeting currently taking place in Chicago (2-6 June), it’s been another busy week for cancer drug development news.

Pharmaceutical Companies 130

Pharmaceutical Companies Clinical Trials Drugs Pharmaceuticals 130

Drug Discovery World

SEPTEMBER 28, 2023

Earlier this year, we explored the microbiome and its role in drug development across various therapeutic areas. Ongoing impactful trials are investigating the potential for microbiome-based diagnostic tests for endometriosis 5 and PCOS 6 using blood, faecal, vaginal, and/or endometrial samples.

Clinical Trials 162

Clinical Trials Regulations Trials Drug Development 162

Drug Discovery World

MAY 6, 2024

In this article, DDW’s Diana Spencer highlights several prominent hotspots that are taking the lead on advancing European drug discovery and development. Europe is traditionally a life sciences powerhouse, with a strong tradition in pharmaceutical discovery. The CDD will sponsor and manage KWF-supported trials.

Drugs 147

Drugs Science Molecular Biology Clinical Trials 147

Drug Discovery World

DECEMBER 28, 2023

To date, much of the conversation in oncology research and development has focused on treatments for adults. However, when it comes to drug development, scarcity in paediatric cancer diagnoses – especially when compared to adults – often comes with its own set of challenges. We owe nothing less to them.

Research 130

Research Clinical Trials Hospitals Trials 130

Drug Discovery World

FEBRUARY 13, 2024

AI has long been touted as having the potential to speed up drug development, particularly in the early-drug discovery stages, by helping researchers find suitable drug targets that can better tackle diseases. But is AI the answer to the industry’s development challenges?

Small Molecule 147

Small Molecule Drugs Therapies Pharmaceutical Companies 147

PPD

MARCH 26, 2024

The PPD clinical research business of Thermo Fisher Scientific conducts an annual survey of more than 150 leaders at pharmaceutical companies around the globe to assess trends in drug discovery and development, including preferences around outsourcing and functional service provider (FSP) utilization.

Pharmaceutical Companies 98

Pharmaceutical Companies Clinical Research Clinical Development Drug Development 98

Conversations in Drug Development Trends

DECEMBER 7, 2023

Amidst a shifting clinical landscape characterized by increasingly complex trial designs and growing patient subpopulations, many contract research organizations (CROs) have adopted a “one-stop-shop” strategic approach. Moreover, these delays impact getting potentially lifesaving therapies to patients in need.

Clinical Trials 136

Clinical Trials Clinical Development Trials Pharmaceutical Companies 136

H1 Blog

JULY 30, 2024

Increasing diversity in clinical trials not only makes the findings more relevant to various patient groups, but also enhances knowledge about the disease or medical product being studied. Hence, pharmaceutical companies need to start making preparations to ensure compliance with the new requirements.

FDA 59

FDA Compliance Clinical Trials Pharma Companies 59

The Pharma Data

MAY 5, 2022

Validated Measurable Residual Disease Assays are Critical for the Rapid Development of Future Novel Therapeutics for Patients with Acute Myeloid Leukemia. 1 Clinical trials for new therapies in AML are becoming increasingly lengthy to complete based on the traditional clinical endpoint of survival.

Disease 52

Disease Drug Development Clinical Trials Pharmaceutical Companies 52

DrugBank

MARCH 7, 2024

The Quest for Ozempic-Like Alternatives Ozempic, a GLP-1 receptor agonist developed by Novo Nordisk, has demonstrated remarkable efficacy in promoting weight loss and improving metabolic health. Key Players and Challenges For pharmaceutical giants like Novo Nordisk and Eli Lilly, 2024 presents both opportunities and challenges.

Pharmaceutical Companies 80

Pharmaceutical Companies Pharmaceuticals Clinical Trials Pharmacokinetics 80

Drug Discovery World

NOVEMBER 11, 2022

BioSenic’s arsenic trioxide (ATO) autoimmune disease platform has completed a successful Phase IIb trial in chronic Graft vs Host Disease (cGVHD) and is preparing to move to a Phase III trial. . Pharma companies team-up to reduce emissions .

Pharma Companies 130

Pharma Companies Drugs Pharmaceutical Companies Disease 130

H1 Blog

SEPTEMBER 14, 2023

As pharmaceutical companies turn to CROs (Clinical Research Organizations) for trial design and technology, there are new opportunities emerging with healthcare data intelligence that can help ensure a bright future for the industry and to make trials more effective, efficient and accessible. million data points.”

Clinical Trials 59

Clinical Trials Pharmaceutical Companies Trials Pharmaceuticals 59

PPD

JUNE 20, 2024

Acceleration in every step of clinical research is critical to pharmaceutical developers. Despite advances in technology and innovation, pharmaceutical leaders say that trials are increasingly complex, particularly when it comes to patient recruitment and site engagement. With a median delay of 12.2

Clinical Research 52

Clinical Research Research Pharmaceuticals Clinical Trials 52

Drug Discovery World

JULY 5, 2023

Companion diagnostics are vital for the development of precision oncology treatments which are more targeted, more specific, and are less likely to have side effects. Now, we’re seeing more academic institutions at the forefront of running clinical trials and diagnostic solutions to bring treatments directly to patients.

Research 246

Research Immune Response Pharmaceutical Companies Treatment 246

The Pharma Data

JANUARY 12, 2021

a leader in precision medicine and artificial intelligence (AI)-enabled patient-centric oncology clinical trial enrollment, announced today it has launched its SYNERGY-AI Oncology Clinical Trial Command Center (OCTCC) with the mission to disrupt and accelerate the clinical trial enrollment process.

Clinical Trials 52

Clinical Trials Trials Clinical Research Pharmaceutical Companies 52

Perficient: Drug Development

SEPTEMBER 10, 2024

Powering Patient-Centric Clinical Trials with AI and Data Explore how Life Sciences Cloud leverages AI to power comprehensive, customized, next-generation clinical trials for pharmaceutical companies. Gain insights into AI-driven solutions for optimizing clinical trials and enhancing customer experiences.

Science 52

Science Clinical Trials Pharmaceutical Companies Trials 52

Conversations in Drug Development Trends

APRIL 15, 2024

As the clinical research landscape continually evolves, the choice of a Contract Research Organization (CRO) partner can significantly impact the success of drug development programs. The Advantages of Midsize CROs In contrast to large CROs, midsize CROs like Worldwide Clinical Trials offer a unique value proposition to the market.

Clinical Trials 52

Clinical Trials Clinical Development Clinical Research Pharmaceutical Companies 52

Vial

FEBRUARY 15, 2024

Clinical trials play a crucial role in advancing medical breakthroughs, but effective management is essential to unlock their full potential. Pharmaceutical companies often face challenges in conducting clinical trials due to the need for substantial knowledge, time, and resources. over the forecast period (2022-2030).

Pharma Companies 52

Pharma Companies Clinical Trials Compliance Trials 52

Conversations in Drug Development Trends

MAY 14, 2024

As the strategists for Worldwide Clinical Trials’ rare disease sponsors, we design customized solutions that make a difference in achieving successful outcomes. Our approach is informed by our combined 30+ years in rare disease clinical development and our time in various stakeholder roles, such as scientists, CRAs, and project managers.

Disease 81

Disease Clinical Trials Trials Pharmaceutical Companies 81

Vial

APRIL 10, 2024

The increasing costs associated with in-house drug development have prompted biotech and pharmaceutical companies to increasingly outsource to contract research organization s (CROs) for assistance. Vial’s track record includes over 750 completed trials and a network of more than 35 research sites.

Clinical Trials 52

Clinical Trials Trials Compliance Clinical Research 52

Drug Discovery World

DECEMBER 18, 2023

Digital biomarkers promise to transform preventive medicine and clinical trials, but also raise issues of security, regulation and potential disparities in access. Deepika Khedekar, Clinical Trial Lead at IQVIA, provides an overview of the pros and cons, and suggests a possible solution.

Clinical Research 147

Clinical Research Research Clinical Trials Trials 147

DrugBank

APRIL 12, 2024

Over the past decade, the drug discovery landscape has been revolutionized by the adoption of artificial intelligence (AI) and machine learning (ML), witnessing early adopters leapfrog into pioneering technologies aimed at streamlining the drug development process and curtailing associated costs.

Drugs 82

Drugs Pharmaceutical Companies Clinical Trials Pharmaceuticals 82

Drug Discovery World

JULY 15, 2024

Dr Alexandra Sapetschnig, Group Leader at STORM Therapeutics, described the event as one that “really set the agenda for oncology research in 2024” through the display of new approaches and methods that are expanding opportunities in drug development. This bodes well for potential future research and therapies,” she adds.

Research 130

Research Clinical Pharmacology Therapies RNA 130

Predictive Oncology

FEBRUARY 7, 2023

“We’re providing that richness of tumor diversity and the population diversity that normally the companies will not be able to see until they are in a clinical trial and [the drug is] challenged against a multitude of different patients.”

Pharmaceutical Companies 52

Pharmaceutical Companies Clinical Trials Trials Pharmaceuticals 52

The Pharma Data

JULY 8, 2021

The update includes an addition to the Indications and Usage section of the label (Section 1) to emphasize the disease stages studied in the clinical trials, as seen below ( italics to note updated language). Continued approval for this indication may be contingent upon verification of clinical benefit in confirmatory trial(s).

Clinical Trials 52

Clinical Trials FDA Approval Trials FDA 52

Drug Discovery World

AUGUST 1, 2023

Drug development Kite later announced results from a Phase III trial of its CAR-T cell therapy Yescarta (axi-cel) in which it was compared against standard of care (SOC) treatment in patients with relapsed or refractory large B-cell lymphoma (R/R LBCL).

Drugs 130

Drugs Licensing Licensing Engineering 130

Drug Discovery World

FEBRUARY 10, 2023

For life sciences companies across Sweden and the Nordics in general, generating funding equal to international partners in places like the US has proven difficult. He is now a founding partner of EIR Ventures, a venture capital firm investing in innovative companies across the Nordics.

Science 130

Science Drugs Pharmaceutical Companies Pharmaceuticals 130

Drug Target Review

FEBRUARY 1, 2024

But commitment to neuroscience drug development is critically important given the significant unmet medical needs and the ways in which patients, caregivers, and families suffer. This can present challenges when attempting to recruit an enriched patient population for clinical trials.

Therapies 104

Therapies Drug Development Disease Clinical Development 104

Conversations in Drug Development Trends

MAY 14, 2024

As the strategists for Worldwide Clinical Trials’ rare disease sponsors, we design customized solutions that make a difference in achieving successful outcomes. Our approach is informed by our combined 30+ years in rare disease clinical development and our time in various stakeholder roles, such as scientists, CRAs, and project managers.

Disease 52

Disease Clinical Trials Trials Pharmaceutical Companies 52

Drug Discovery World

JANUARY 31, 2023

Biopharmaceutical Lifecycle Management (BPLM) is key to delivering novel therapies and lifesaving drugs to the world. Over the last decade, many pharmaceutical companies have undertaken internal ‘harmonisation’ projects. Discrepancies are also exacerbated as large biopharma companies grow through acquisitions.

Production 246

Production Engineering Pharmaceutical Companies Clinical Trials 246

Advarra

AUGUST 16, 2022

Orphan drugs have historically faced a number of barriers, such as limited research and development (R&D) investment due to an expected lack of profitability as well as challenges in clinical trial design and recruitment. Before 1983, only 38 orphan drugs had received U.S. Food and Drug Administration (FDA) approval.

Disease 52

Disease Clinical Trials FDA Approval FDA 52

Drug Target Review

JANUARY 8, 2024

We are at the forefront of drug development in an area of research called cellular rejuvenation, which is an approach that has the potential to address many diseases of ageing by restoring aged and injured cells to a more youthful and resilient state. a commercial stage pharmaceutical company.

Science 145

Science Disease FDA Approval Pharmaceutical Companies 145

Drug Discovery World

FEBRUARY 22, 2023

Craig Caceci, Managing Director at Terebellum, offers guidance to pharmaceutical companies that are in the position to take their drugs to market. Hopefully you’ll have started this prior to launch, and data pushing from the clinical trial post-launch is more important than ever to support your sales reps.

Specialty Pharmacies 130

Specialty Pharmacies Drugs Marketing Clinical Trials 130

Drug Discovery World

MARCH 13, 2024

Following this, a medical innovation and development centre, Biopolis Hub, was opened in 2005. In terms of drug discovery, every year the agency awards national grants through the Singapore Therapeutics Development Review (STDR), designed to boost the quality and quantity of drug development and biotech pipelines in Singapore 3.

Government 173

Government Science Pharmaceuticals Vaccine 173